4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0001567619-21-005967
Options or other derivatives
- Kirn David acquired 150,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-03-08 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +150,000 | 150,000 | D |
Loading xslF345X03/doc1.xml…